AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04991675 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: pelvic floor muscle exercises
Description: During the first visit, the anatomy of the pelvic floor and the purpose of the program were explained. Exercises were taught in the supine position, as described by Kegel (1948), it was confirmed that the women learned to use the correct muscles with vaginal palpation. During the exercise, the participants were informed not to pull the abdomen inwards, not to tighten their legs and hip muscles, and not move their pelvis.
Study NCT04991675 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: diaphragmatic breathing exercises
Description: During the first visit, the anatomy of the diaphragm and abdominal wall and the purpose of the program were explained. Diaphragmatic breathing exercise was taught in supine position. The movement of the symphysis pubis was examined to confirm that the pelvic floors' movement was also involved breathing. Abdominal palpation was used to elicit unawareness of the diaphragmatic breathing and to assess whether contractions were performed correctly.
Study NCT03205683 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intraneural facilitation (INF)
Description: INF is a novel non-invasive therapy based on the principle of restoring vascular function at the capillary level in peripheral nerve.
Study NCT03205683 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham INF
Description: Will be performed by a different therapist than actual INF. The patient will be asked to do the following combination of passive range of motion (PROM) and active ROM activities to promote blood flow in the affected arm.
Study NCT02384733 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Loco-regional RT
Study NCT02384733 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Loco-regional RT
Study NCT00823667 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: educational intervention
Description: Palliative care intervention at weeks 3,4,5 and 6 post study enrollment
Study NCT00823667 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: medical chart review
Description: Occurs at 1 year post study enrollment
Study NCT00823667 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: questionnaire administration
Description: Occurs at baseline, 6 weeks, 12 weeks, 24 weeks, 36 weeks and 52 weeks post study enrollment
Study NCT00823667 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: end-of-life treatment/management
Description: Occurs at baseline, 6 weeks, 12 weeks, 24 weeks, 36 weeks and 52 weeks post study enrollment
Study NCT00823667 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: psychosocial assessment and care
Description: Occurs at baseline, 6 weeks, 12 weeks, 24 weeks, 36 weeks and 52 weeks post study enrollment
Study NCT02222649 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D3
Description: High dose of 200,000 IU of cholecalciferol orally in a single dose
Study NCT02222649 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsules of starch, no therapeutic action
Study NCT03726502 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ureteroscopy with safety guide-wire
Description: ureteroscopy with use of safety guide-wire in treatment of ureteral stone
Study NCT03726502 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: ureteroscopy alone
Description: ureteroscopy without use of safety guide-wire in treatment of ureteral stone
Study NCT03726502 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: without safety guide-wire
Description: ureteroscopy without use of safety guide-wire in treatment of ureteral stone
Study NCT03726502 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: with safety guide-wire
Description: ureteroscopy with use of safety guide-wire in treatment of ureteral stone
Study NCT01739738 — intervention group
Intervention type: DEVICE
Intervention: Ureteral Stent
Description: patients who need to receive stent as per standard of care
Study NCT03031782 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: secukinumab
Description: secukinumab is a high-affinity fully human monoclonal anti-human antibody that targets IL-17A and neutralizes activity.
Study NCT02477072 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ACT
Description: Blood samples for ACT will be collected following induction of anesthesia, 30 minutes after heparin administration, and on arrival in the recovery room.
Study NCT00262028 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MenACWY-CRM Vaccine
Study NCT00262028 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: MenACWY-PS Vaccine
Study NCT03031782 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Matched placebo to AIN457 for use in the double blind Treatment Period 2
Study NCT01941706 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Project UPLIFT
Description: Developed for home-based treatment of depression in people with epilepsy, Project UPLIFT is based upon Mindfulness-based Cognitive Therapy for depression. It includes 8 modules, group-delivered by either telephone or Web. Trainees and people with epilepsy co-facilitate the groups, supervised by a licensed mental health professional.The co-facilitators are trained and supervised by the Principal Investigator, a Georgia-licensed clinical psychologist and Associate Professor of Behavioral Science and of Epidemiology in public health. Activities are designed to increase knowledge about depression; monitoring, challenging, and changing thoughts; coping and relaxing; attention and mindfulness; focusing on pleasure; the importance of reinforcement, and preventing relapse.
Study NCT01373723 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer
Description: Cost-effectiveness analysis of 3 strategies to increase the recruitment of population screening for cervical cancer. These interventions will be compared to the current opportunistic screening strategy
Study NCT00823667 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: quality-of-life assessment
Description: Occurs at baseline, 6 weeks, 12 weeks, 24 weeks, 36 weeks and 52 weeks post study enrollment
Study NCT02968342 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Vaginal progesterone 8%
Description: vaginal self application
Study NCT02968342 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone 8%
Description: vaginal self application
Study NCT03040674 — intervention group
Intervention type: PROCEDURE
Intervention: Cell therapy
Description: Each participant will receive cell therapy with stem cells harvested either from peripheral blood or from bone marrow plus peripheral blood; after harvest, cells are processed and returned to the patient via peripheral circulation on the same day
Study NCT00036634 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir DF
Description: Tenofovir DF tablet administered orally once daily
Study NCT01755130 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Photoacoustic Imaging
Description: Undergo LOUISA 3D
Study NCT02477072 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TEG
Description: Blood samples for TEG will be collected following induction of anesthesia, 30 minutes after heparin administration, and on arrival in the recovery room.
Study NCT01479842 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BTK inhibitor PCI-32765
Description: Given PO
Study NCT01479842 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rituximab
Description: Given IV
Study NCT01479842 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bendamustine hydrochloride
Description: Given IV
Study NCT01479842 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacogenomic studies
Description: Correlative studies
Study NCT01479842 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study NCT01479842 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT01803828 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tadalafil
Description: 20 mg/die (1 capsule)
Study NCT02477072 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TEG
Description: Blood samples for TEG will be collected following induction of anesthesia, 30 minutes after heparin administration, and on arrival in the recovery room.
Study NCT02477072 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ankle-brachial index
Description: Peripheral blood flow will be assessed prior and after surgery using the ankle-brachial and toe-brachial indexes.
Study NCT02477072 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ankle-brachial index
Description: Peripheral blood flow will be assessed prior and after surgery using the ankle-brachial and toe-brachial indexes.
Study NCT02477072 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Toe-brachial index
Description: Peripheral blood flow will be assessed prior and after surgery using the ankle-brachial and toe-brachial indexes.
Study NCT02477072 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Toe-brachial index
Description: Peripheral blood flow will be assessed prior and after surgery using the ankle-brachial and toe-brachial indexes.
Study NCT02477072 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin
Description: Heparin doses will be administered according to the assigned group.
Study NCT01803828 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 20 mg/die (1 capsule)
Study NCT02959866 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: online income tool
Description: An online tool that uses information about the patient to develop a tailored list of financial benefits that they are eligible to apply for.
Study NCT02477072 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Heparin
Description: Heparin doses will be administered according to the assigned group.
Study NCT02477319 — intervention group
Intervention type: OTHER
Intervention: Observational
Study NCT01280656 — intervention group
Intervention type: DRUG
Intervention: Conventional Interferon
Description: Conventional interferon according to the standard of care and aligned with the local prescription instructions
Study NCT01280656 — intervention group
Intervention type: DRUG
Intervention: Peginterferon Alfa-2a
Description: Peginterferon alfa-2a according to the standard of care and aligned with the local prescription instructions
Study NCT01280656 — intervention group
Intervention type: DRUG
Intervention: Peginterferon Alfa-2b
Description: Peginterferon alfa-2b according to the standard of care and aligned with the local prescription instructions
Study NCT01280656 — intervention group
Intervention type: DRUG
Intervention: Ribavirin
Description: Ribavirin according to the standard of care and aligned with the local prescription instructions
Study NCT02718456 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expedited CD4 testing
Study NCT02718456 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supplemental peer counseling
Study NCT02595788 — intervention group
Intervention type: OTHER
Intervention: Change from supine to prone position
Description: Change from supine to prone position
Study NCT02885610 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo plus standard therapy
Description: Standard therapy comprises any of the following (alone or in combination): corticosteroids, antimalarials, non-steroidal anti-inflammatory drugs (NSAIDs), and immunosuppressive and immunomodulator therapy(i.e.,azathioprine,mycophenolate ,cyclophosphamide,methotrexate,leflunomide, Tacrolimus ,ciclosporin )
Study NCT02885610 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RC18 80 mg plus standard therapy
Description: Standard therapy comprises any of the following (alone or in combination): corticosteroids, antimalarials, non-steroidal anti-inflammatory drugs (NSAIDs), and immunosuppressive and immunomodulator herapy(i.e.,azathioprine,mycophenolate ,cyclophosphamide,methotrexate,leflunomide, Tacrolimus ,ciclosporin )
Study NCT02885610 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RC18 160 mg plus standard therapy
Description: Standard therapy comprises any of the following (alone or in combination): corticosteroids, antimalarials, non-steroidal anti-inflammatory drugs (NSAIDs), and immunosuppressive and immunomodulator herapy(i.e.,azathioprine,mycophenolate ,cyclophosphamide,methotrexate,leflunomide, Tacrolimus ,ciclosporin )
Study NCT02885610 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RC18 240 mg plus standard therapy
Description: Standard therapy comprises any of the following (alone or in combination): corticosteroids, antimalarials, non-steroidal anti-inflammatory drugs (NSAIDs), and immunosuppressive and immunomodulator therapy(i.e.,azathioprine,mycophenolate ,cyclophosphamide,methotrexate,leflunomide, Tacrolimus ,ciclosporin )
Study NCT02416297 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation
Description: Flapless cortical perforations will be made 8 months minimum after dental extraction. Surgical protocol will be flapless to preserve periodontal health. After local anesthesia, 3 micro osteoperforations will be done with manual instrument, between apex to the contour of free gum between the canine and second pre-molar. Perforations near each tooth will have 6-8 mm depth
Study NCT00038376 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isotretinoin (Accutane)
Description: 0.5 mg/k (1.0 mg/k total) by mouth twice a day
Study NCT00038376 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interferon Alpha
Description: Starting dose of 3 MU injected under skin once a day for 12 weeks.
Study NCT02558803 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simple Reminder
Description: A simple reminder prompt in which CHICA will provide an immunization reminder to the physician that the child is eligible for the 2nd or 3rd dose of vaccine.
Study NCT04099186 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: catheter directed hydro-mechanical fragmentation of pulmonary embolism
Description: A(6)F multipurpose catheter will be advanced over a guide wire under fluoroscopic guidance and used to measure right heart and pulmonary artery pressures, then mechanical catheter fragmentation will be done using a pigtail catheter. The catheter will be quickly spun manually so as to fragment the central thrombus and establish initial flow into pulmonary artery , then 200 ml saline will be injected via power injector to aid fragmentation of thrombus
Study NCT02649478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone / Salmeterol
Description: Fluticasone propionate (100 mcg) and salmeterol xinafoate (50 mcg) administered via the Vectura LOMI inhaler device
Study NCT02649478 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02649478 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Advair Diskus 100/50
Description: Advair (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate administered via the Diskus inhaler device)
Study NCT03803488 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DropSafe safety pen needle
Study NCT00596466 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pregabalin
Description: pregabalin
Study NCT04786327 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Minimal invasive flap technique
Description: contained defect treated with Minimally invasive flap
Study NCT03543540 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nexvax2
Description: Nexvax2 injections: 14 in total at twice weekly intervals
Study NCT03543540 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo injections: 14 in total at twice weekly intervals
Study NCT02097056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil HCL
Description: Donepezil HCl 23 mg once daily, just before bed, for 24 weeks
Study NCT04786327 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally invasive flap with root conditioning (EDTA) and platelet rich fibrin
Description: contained defect treated by Minimally invasive flap with root conditioning (EDTA) and platelet rich fibrin graft
Study NCT04786327 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: minimally invasive flap with root contioning by EDTA and growth factor enhanced matrix GEM21S
Description: contained defect treated with Minimally invasive flap with root conditioning (EDTA) and growth factor enhanced matrix application in the defect
Study NCT04907201 — intervention group
Intervention type: PROCEDURE
Intervention: Cryoneurotomy
Description: Cryoneurotomy or application of a low temperature probe with guidance of ultrasound which is offered to the patients with lower limbs refractory spasticity as a part of their medical cares.
Study NCT03906240 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moral Elevation intervention
Description: The intervention will be administered twice per week for 8 sessions total. The intervention will include two types of moral elevation exercises related to witnessing virtuous behavior and subsequently setting session goals aimed to facilitate social engagement.
Study NCT00731913 — intervention group
Intervention type: OTHER
Intervention: Absorable, monofilament sutures: Monosyn and Monocryl
Description: Subjects were randomized to Monosyn vs. Monocryl suture arms. The designated skin lesion was removed surgically. The surgical repair of the defect was performed by dividing the wound in half by a single Prolene suture. The appropriate suture was opened by the Study Coordinator and passed sterilely to the surgical technician. The surgical technician loaded the suture, and passed it in a blinded fashion to the physician who closed the appropriate half of the surgical defect. One half of the wound was closed with one suture and the other half was closed with the other suture. Each patient served as their own control, as both sutures were used in each study patient.
Study NCT02648659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ilaprazole
Description: Ilaprazole 10mg 1tablet qid(4 times/day)
Study NCT02648659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: Amoxicillin 500mg 1capsule qid(4times/day)
Study NCT02648659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Description: Clarithromycin 500mg 1tablet bid(2times/day)
Study NCT02648659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole
Description: Metronidazole 250mg 2tablets tid(3times/day)
Study NCT03219788 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: All the patient will be anesthetized using a standard anesthetic technique. One ml normal saline will be given
Study NCT03219788 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Remifentanil 0.1 ug/kg
Description: All the patient will be anesthetized using a standard anesthetic technique. One ml normal saline contains 0.1 ug/kg Remifentanil will be given
Study NCT03219788 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Remifentanil 0.2 ug/kg
Description: All the patient will be anesthetized using a standard anesthetic technique. One ml normal saline contains 0.2 ug/kg Remifentanil will be given
Study NCT02185820 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Study NCT02185820 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Study NCT02185820 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Study NCT00054821 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ankle distraction permitting motion
Description: External fixator is applied to ankle joint for 85 - 95 days; ankle motion is permitted
Study NCT00054821 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ankle distraction without motion
Description: External fixator is applied to ankel joint for 85 - 95 days; ankle motion is not permitted
Study NCT03152721 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Parkinson KinetiGraph
Description: The Parkinson Kinetigraph (PKG) is a wrist-worn accelerometer shaped as a watch. It records spontaneous movements and for every two minutes provides a bradykinesia score and a dyskinesia score. Furthermore it analysis movement for tremor-like episodes and registers the time with tremulous movements as well as time with extreme immobility suggesting sleep. The device can be programmed with drug intake times and provide a reminder signal. Intake of drug can be indicated on the device.
Study NCT03152721 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Self assessment
Description: Administration of self assessment questionnaires are made within 2 weeks from starting a PKG recording. The assessments are Parkinson Disease Quality of life 8 question short version and the Non Motor Symptom in Parkinson Disease Questionnaire.
Study NCT03152721 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self assessment
Description: Administration of self assessment questionnaires are made within 2 weeks from starting a PKG recording. The assessments are Parkinson Disease Quality of life 8 question short version and the Non Motor Symptom in Parkinson Disease Questionnaire.